Akhter, A., Shirazi, J
Nefrocenter Research & Nyx Start-up Study Group on diabetes: Diabetologists: Sandro Gentile, Giuseppina Guarino, Felice Strollo, Gerardo Corigliano, Marco Corigliano, Maria Rosaria Improta, Carmine Martino, Antonio Fasolino, Antonio Vetrano, Agostino Vecchiato, Domenica Oliva, Clelia Lamberti, Domenico Cozzolino, Clementina Brancario, Luca Franco
Learn more about the ingredients we use here:
Tirzepatide trials report similar tolerability, with 4-8% discontinuation due to adverse events, predominantly gastrointestinal
Given these short windows, staying organized with the MeAgain with GLP-1 app ensures you never lose track of a vial's potency